FDA Reiterates Intention To Regulate Only A Small Portion Of Mobile Medical Apps
This article was originally published in The Gray Sheet
Executive Summary
On the last day of hearings by three House Energy and Commerce subcommittees March 19-21, CDRH Office of Device Evaluation Director Christy Foreman largely reiterated FDA’s previously stated approach to regulating mobile medical apps. Meanwhile, Energy and Commerce Committee Vice Chair Marsha Blackburn, R-Tenn., hinted at legislation on the issue
You may also be interested in...
ODE Chief Foreman Departs Device Center; Maisel Will Fill In
Christy Foreman is taking an associate director role in FDA’s Center for Tobacco Products, leaving a vacancy at the top of the Office of Device Evaluation. CDRH Chief Scientist William Maisel will fill in while the device center seeks a replacement.
Bipartisan House Bill Introduced To Curb FDA Health IT Oversight
The SOFTWARE Act, introduced in the House by Rep. Marsha Blackburn, R-Tenn., with support from House members on both sides of the aisle, attempts to redefine regulation of health information technology, and, in particular, limit FDA’s oversight to “products that pose a potential risk to human health.”
Bipartisan House Bill Introduced To Curb FDA Health IT Oversight
The SOFTWARE Act, introduced in the House by Rep. Marsha Blackburn, R-Tenn., with support from House members on both sides of the aisle, attempts to redefine regulation of health information technology, and, in particular, limit FDA’s oversight to “products that pose a potential risk to human health.”